Patients with a diagnosis of HLH-related disorders
Patient . | Disease . | Age/sex . | NK LU . | % NK . | % perforin . | ||
---|---|---|---|---|---|---|---|
NK . | CD8 . | CD56 . | |||||
P15 | Chediak-Higashi syndrome | 7 mo/M | 0.0↓ | 3 | 95 | 1 | 34 |
P16 | XLP | 15 mo/M | 1.5↓ | <1↓ | 99 | 32↑ | 23 |
P17 | JRA + MAS | 22 y/F | 4.6 | 5↓ | 82↓ | 2↓ | 7↓ |
Normal values | |||||||
0-1 y | 3-17 | 91-97 | 0-3 | 4-30 | |||
1-15 y | 4-22 | 81-91 | 2-11 | 12-34 | |||
>3.2 | |||||||
15-50 y | 7-31 | 86-98 | 8-28 | 30-77 |
Patient . | Disease . | Age/sex . | NK LU . | % NK . | % perforin . | ||
---|---|---|---|---|---|---|---|
NK . | CD8 . | CD56 . | |||||
P15 | Chediak-Higashi syndrome | 7 mo/M | 0.0↓ | 3 | 95 | 1 | 34 |
P16 | XLP | 15 mo/M | 1.5↓ | <1↓ | 99 | 32↑ | 23 |
P17 | JRA + MAS | 22 y/F | 4.6 | 5↓ | 82↓ | 2↓ | 7↓ |
Normal values | |||||||
0-1 y | 3-17 | 91-97 | 0-3 | 4-30 | |||
1-15 y | 4-22 | 81-91 | 2-11 | 12-34 | |||
>3.2 | |||||||
15-50 y | 7-31 | 86-98 | 8-28 | 30-77 |
A patient with Chediak-Higashi syndrome in accelerated phase showed values within the normal range for his age. A patient with XLP showed markedly increased perforin-expressing CD8+ T cells. A patient with JRA complicating MAS showed decreased proportions of perforin-expressing cells in all cytotoxic cell types.